🇺🇸

US SEC Filing Intelligence

· daily

Global High-Priority Regulatory Events — April 13, 2026

Across 50 filings dated April 13, 2026, dominant themes include major M&A activity like Somnigroup's $2.5B all-stock acquisition of Leggett & Platt (yielding $11.2B combined sales, immediate EPS accretion), biotech IPO pursuits (Alamar Biosciences +195% YoY revenue to $74.2M, Kailera's Phase 3 obesity pipeline), and a wave of Indian insolvencies/open offers (AGS Transact CIRP, Reliance Home Finance CoC meeting, multiple open offers at 26% stakes). Period-over-period trends show polarized performance: revenue growth in 6/18 reporting companies averaging +85% YoY (e.g., Alamar 195%, EACO 17.7%), but margin compression in 5/18 (Digital Ally to 10% from 23%, ALT5 to 41% from 48%) and net losses widening in microcaps (ALT5 -$344k from -$7.5k). RBI filings highlight persistent liquidity deficits (₹5.54L Cr absorption, SDF heavy usage), signaling tight Indian money markets. Critical implications: M&A catalysts for industrials, delisting risks (Sow Good Nasdaq notice), leadership transitions (Conagra CEO change, AdvanSix CFO), with forward catalysts like Phase 3 readouts (Kailera 2028), LEG merger close YE2026. Portfolio pattern: Outliers in biotech/health (positive sentiment 7/10) vs distress in small caps/fintech (negative/mixed 8/12).

50 high priority 50 total filings
· daily

US Earnings Financial Results SEC Filings — April 13, 2026

Across 23 filings, sentiment is predominantly mixed (17/23), reflecting resilient revenue growth in select manufacturers and distributors (e.g., Arts-Way +29% YoY sales, EACO +17.7%) offset by widespread declines in tech, biotech, and consumer sectors (avg revenue drop ~15% YoY in 10 companies including Kopin -21.9%, Biomerica -21.6% 9M). Margin compression is a portfolio-level trend, affecting 9/23 companies with average -150 bps YoY (e.g., Digital Ally to 10% from 23%, Wetouch 31.8% from 32.2%), driven by cost pressures and crypto losses (Pineapple -$23M FV loss). Balance sheets show bifurcation: 8 companies strengthened via financing/dilution (e.g., Pineapple assets x9 to $48.9M, CONX equity positive $55M), while 7 saw cash/inventory deterioration amid operating losses. Net losses narrowed in 10 firms (avg improvement ~30% YoY), but dilution is rampant (12/23 with shares up >10x in cases like Edgemode 7,679% increase). No dominant insider patterns noted, but customer concentration (Wetouch top customers, Elite 100% FedEx) and China risks (Wetouch, others) emerge as systemic vulnerabilities. Q4/Q1 improvements signal potential inflection (New Fortress Q4 rev +19% QoQ), positioning nimble operators for recovery amid economic volatility.

23 high priority 23 total filings
· daily

US SEC Trading Suspension Halt Orders — April 13, 2026

Two small-cap companies, VEEA Inc. and Twin Vee PowerCats (VEEE), disclosed critical Nasdaq listing compliance failures in their April 2026 8-K filings, highlighting a portfolio-level theme of micro-cap distress amid prolonged bid price and market value deficiencies. VEEA failed Minimum Bid Price ($1.00), MVPHS ($15M), and MVLS ($50M) requirements by the March 30, 2026 deadline but secured a transfer to Nasdaq Capital Market (effective April 9, 2026) and a second 180-day extension to September 28, 2026, yielding mixed sentiment; VEEE received a delisting notice with no remediation path disclosed, paired with dilutive share authorization increases, driving negative sentiment. No period-over-period financial trends, revenue growth, or margin data were reported, but compliance failures imply QoQ/YOY deterioration in stock price (below $1 for VEEA since Sept 2025) and market cap metrics. Capital allocation shows VEEE pursuing defensive governance (classified board, 60% removal threshold) and massive share authorization (500M common shares), signaling entrenchment amid distress. Market implications include heightened delisting risks, potential reverse splits, and trading halts, creating short opportunities while VEEA's extension offers limited near-term stability. Overall, 2/2 filings exhibit high materiality (9/10), underscoring regulatory pressure on Nasdaq micro-caps with no bullish portfolio trends evident.

2 high priority 2 total filings
· daily

US Corporate Distress Financial Stress SEC Filings — April 13, 2026

The 31 filings in the USA Corporate Distress & Bankruptcy stream reveal a surge in liquidity-seeking actions amid compliance pressures, with 6 companies (ClearOne, Veea, Sow Good, Twin Vee, Wheeler, Trinseo) facing Nasdaq listing deficiencies or delistings based on recent 10-K equity shortfalls and bid price failures, signaling widespread balance sheet weakness. Debt restructurings dominate positively (10 filings including Marathon Petroleum $5B revolver, AdaptHealth $1.1B facility at lower spreads, MPLX $2.5B), extending maturities and boosting liquidity, though Trinseo's interest payment waivers highlight acute distress. Equity offerings and convertibles (Newton Golf $1.35M funded, Angel Studios $30M priced, ImageneBio $30M PIPE) provide near-term cash but risk dilution, while M&A like Somnigroup/Leggett $2.5B all-stock deal offers turnaround potential with $50M synergies. No broad YoY/QoQ revenue declines explicitly stated, but implied deterioration from equity drops below $2.5M-$15M thresholds and contract losses (Ameriguard 58% 2026 rev). Portfolio trend: Margin-neutral to compressed operations driving 4 lease terminations/cuts, but capital raises counterbalance; sector implication is heightened bankruptcy risk for microcaps vs investment-grade refinancings signaling resilience.

31 high priority 31 total filings
· daily

US Executive Officer Management Changes SEC — April 13, 2026

Across 23 SEC filings on USA executive and director changes dated April 13, 2026, the overriding theme is leadership optimization for growth, with 16 positive appointments/retainments (70%) outpacing 7 departures/resignations, including high-materiality CEO shifts at Conagra Brands (new CEO June 1) and TVA (separation). No explicit period-over-period financial declines reported in any filing; instead, stability is inferred from retention incentives like ProFrac's 287k PSUs to CEO/Exec Chair and Vistagen's options to all employees, contrasting with sector peers facing talent wars. Forward-looking data highlights catalysts such as ALX Oncology's evorpacept milestones in 12-18 months, Commvault's reaffirmed FY2026 guidance, and NET Power's financing expertise for 2.4GW portfolio. Insider activity via equity grants (e.g., CG Oncology $4M options/$1M PSUs to new CFO) signals management conviction, with no sales or pledges noted. Biotech/pharma dominates (9/23 filings) with net positive hires amid clinical pushes, while CFO turnover (8 companies) suggests finance-led transformations. Capital allocation tilts to LTIPs over dividends/buybacks, prioritizing retention; portfolio implication: overweight firms with smooth transitions for alpha in Q2-Q3 2026.

23 high priority 23 total filings
· daily

US Corporate Board Director Changes SEC Filings — April 13, 2026

Across 23 8-K filings from April 13, 2026, focused on USA boardroom changes, a net positive trend emerges with 14 positive sentiment events (board expansions, experienced hires) outpacing 3 negative (sudden resignations) and 6 neutral, signaling proactive leadership refreshes amid 2026 economic pressures. CFO turnover dominates with 9 changes/appointments (e.g., Net Power, AdvanSix, CG Oncology, Commvault, AeroVironment), often with interim bridges and retention incentives like $420K salaries + RSUs, reflecting stabilization efforts. Biotech/pharma sector leads with 7 filings (e.g., Solana CMO exit, ALX CDOO hire for 12-18 month catalysts), while consumer/food sees high-materiality CEO shifts (Conagra 10/10). No broad period-over-period financial declines reported; instead, equity plan expansions (Xenon +30.6% shares) and reaffirmed guidance (Commvault FY2026) indicate capital allocation toward talent retention over buybacks/dividends. Portfolio implication: overweight firms with growth-aligned hires (e.g., Webtoon restructuring for 160M MAUs); monitor CEO voids like TVA for succession risks. Overall, 70% of changes expand expertise in transformation/AI/power markets, positioning for outperformance vs. stagnant peers.

23 high priority 23 total filings
· daily

US Merger & Acquisition SEC Filings — April 13, 2026

A remarkable surge in USA M&A and takeover activity on April 13, 2026, with 11 filings dominated by SPAC business combinations and asset acquisitions in high-growth AI sectors including fintech lending, healthcare analytics, defense detection, and video intelligence. Five positive-sentiment deals (IVCA-Blue Finance $220M, Sizzle-Trasteel $800M, CCTC AI IP, PHGE-DFSL defense, VWAV-xClibre $60M IP) highlight bullish M&A momentum, with no reported YoY/QoQ financial declines but forward-looking earnouts and milestones signaling growth potential. Neutral filings reflect SPAC lifecycle pressures like 3 extensions (Future Vision II $191K note, Inception $12K deposit) and 1 adjournment (Ribbon to Sep 2026), indicating sponsor commitment amid deadline risks but no insider selling or capital cuts. High materiality averages 7/10, with portfolio-level pattern of AI-themed takeovers (4/11 filings) vs routine SPAC housekeeping (4/11). Market implications: Elevated pre-close volatility for SPACs, alpha in AI M&A targets; no sector-wide margin compression or ratio deteriorations noted. Catalyst calendar dense with shareholder votes, F-4 filings, and H2 2026 POCs.

11 high priority 11 total filings
· monthly

US Pre-Market SEC Filings Roundup — April 13, 2026

Overnight SEC filings reveal a surge in biotech catalysts with multiple positive trial readouts (IDEAYA, Spyre, Allogene) signaling potential NDAs and Phase 3 advancements in 2026-2028, alongside robust M&A activity including Somnigroup's $2.5B all-stock acquisition of Leggett & Platt (expected YE2026 close) and Clear Channel's $2.43/share merger. Period-over-period trends show strong revenue acceleration in select small caps and biotechs (Alamar Biosciences +195% YoY to $74.2M, EACO +17.7% QoQ to $117.8M, AITX +26% FY2026 prelim to $7.75M) but widespread margin compression (Digital Ally 23% to 10%, ALT5 48% to 41%) and persistent net losses amid SG&A spikes. Capital allocation leans shareholder-friendly with American States Water's 8.3% dividend hike (71st year) and News Corp's $1B buyback, while IPO filings (Alamar, Kailera, National Healthcare) and ATM offerings signal capital raises amid mixed sentiment. Portfolio-level patterns highlight biotech outperformance vs. small-cap distress (delisting risks, contract losses), with 13F disclosures showing institutional accumulation in tech giants (Apple, Broadcom). Key implications: Biotech sector rotation opportunity pre-market open, monitor M&A regulatory hurdles, and favor revenue growers like EACO over margin squeezes.

25 high priority 20 medium 45 total filings
· daily

New Federal Contractors — April 12, 2026

Two new civilian federal contracts totaling $1,954,256,236 in obligations were awarded, with 0/2 defense-related and a split fully weighted toward civilian agencies including Department of Commerce and Department of Education. The dominant theme is large-scale civilian procurement, led by L3HARRIS TECHNOLOGIES, INC.'s $1.83B award from Department of Commerce, a bullish signal at 7/10 strength and 8/10 materiality despite limited details. MISSOURI HIGHER EDUCATION LOAN AUTHORITY received a neutral $128M obligation (options to $295M) from Department of Education for student loan servicing. Highest-conviction signal is bullish growth for L3Harris in civilian tech-adjacent work. Key watch item is outlay progress from $0 on the MOHELA contract and potential option exercises to $295M.

2 total filings
· daily

Significant Contract Modifications ($10M+) — April 12, 2026

Two significant civilian contract modifications totaling $1,954,256,236 were processed from April 12 to April 12, 2026, with 0/2 defense-related, dominated by the Department of Commerce's $1.83B award to L3Harris Technologies, Inc. The highest-conviction signal is bullish on L3Harris (materiality 8/10, strength 7/10), providing durable revenue visibility in a civilian context despite its defense heritage. A secondary neutral signal emerges from the Department of Education's $128M obligation to nonprofit Missouri Higher Education Loan Authority for student loan servicing, with potential expansion to $295M via options. No cross-contract patterns in recipients or agencies. Key watch item: outlay progress on Missouri Higher Education Loan Authority contract, currently at $0 despite obligation.

2 total filings
· daily

Contract Deobligations Alert — April 12, 2026

Contract deobligations alert for April 12, 2026, aggregates $1,954,256,236 in total obligations across two actions, entirely civilian with 0/2 defense-related and average signal strength 5.5/10. The dominant event is Department of Commerce's $1,826,088,581 deobligation involving L3Harris Technologies, Inc. (2009 award), the highest-conviction bullish signal (strength 7/10, materiality 8/10). Department of Education's $128,167,655 deobligation to Missouri Higher Education Loan Authority (March 31, 2026 award) carries a neutral signal (strength 4/10, materiality 4/10) in student loan servicing. Civilian agencies (Commerce, Education) drive the theme of obligation adjustments. Key watch item: $0 outlays to date on Missouri Higher Education Loan Authority contract, with options expandable to $295,652,367.

2 total filings
· daily

Contract Option Exercises — April 12, 2026

Two civilian contract option exercises totaling $1,954,256,236 in obligations occurred from April 12 to April 12, 2026, with 0 defense-related awards out of 2 total. The dominant theme is large-scale civilian agency commitments, led by Department of Commerce's $1.83B award to L3HARRIS TECHNOLOGIES, INC. and a smaller $128M Department of Education award to MISSOURI HIGHER EDUCATION LOAN AUTHORITY for student loan servicing. Highest-conviction signal is bullish for L3HARRIS TECHNOLOGIES, INC. due to its high materiality (8/10) $1.83B option exercise despite unknowns on revenue impact. Key watch item is outlay progress on MISSOURI HIGHER EDUCATION LOAN AUTHORITY's $128M award, currently at $0 with options to $295M.

2 total filings
· daily

Federal IT & Cybersecurity Contracts — April 12, 2026

The Federal IT & Cybersecurity contracts stream saw a single $1,826,088,581 obligation from April 12, 2026 to April 12, 2026, entirely civilian with 0/1 defense-related awards. Department of Commerce dominated with a $1.83B award to L3HARRIS TECHNOLOGIES, INC., despite the summary labeling it a defense contract. This represents the highest-conviction bullish signal (7/10 strength, 8/10 materiality) for L3Harris in civilian IT/cybersecurity exposure. Key risk includes unknown competition signals and pricing risk, potentially exposing the award to protests or cost overruns. Investors should watch L3Harris (LHX) for civilian revenue diversification amid sparse details on contract moat or sector alignment.

1 total filings
· daily

Mega Contracts Monitor ($100M+) — April 12, 2026

Two civilian mega contracts totaling $1,954,256,236 in obligations were awarded, with 0/2 defense-related and a split of $1.83B from Department of Commerce to L3HARRIS TECHNOLOGIES, INC. and $128M from Department of Education to MISSOURI HIGHER EDUCATION LOAN AUTHORITY. The dominant theme is civilian agency spending on unspecified services (L3Harris) and student loan servicing (Missouri). Highest-conviction signal is bullish for L3HARRIS TECHNOLOGIES, INC. on its $1.83B award, signaling strong position in Commerce procurements. Key watch item is MISSOURI HIGHER EDUCATION LOAN AUTHORITY's $0 outlays to date and potential exercises of options expanding to $295M.

2 total filings
· daily

High-Value Federal Grants ($5M+) — April 12, 2026

High-value federal grants totaling $1,954,256,236 were analyzed for the period April 12, 2026, with a 0/2 defense-related split, entirely civilian-focused. The dominant theme is Department of Commerce awarding $1.83B to L3HARRIS TECHNOLOGIES, INC., dwarfing the $128M Department of Education grant to MISSOURI HIGHER EDUCATION LOAN AUTHORITY. Highest-conviction signal is bullish for L3HARRIS TECHNOLOGIES, INC. due to its massive $1.83B obligation, signaling sustained civilian revenue stream despite the 2009 award date. Key watch item is outlay progress on MISSOURI HIGHER EDUCATION LOAN AUTHORITY's $128M contract, currently at $0 outlayed, with options to $295M.

2 total filings
· daily

General Federal Contracts — April 12, 2026

The two contracts totaling $1,954,256,236 in obligations are entirely civilian (0/2 defense-related), dominated by a massive $1.83B award to L3Harris Technologies, Inc. from the Department of Commerce. This overshadows the smaller $128M obligation to Missouri Higher Education Loan Authority from the Department of Education for student loan servicing. The highest-conviction signal is bullish for L3Harris, reflecting strong materiality (8/10) in a large-scale civilian contract labeled as defense-related. A key watch item is outlay progress on the Missouri Higher Education Loan Authority contract, currently at $0 despite $128M obligated, with options to expand to $295M.

2 total filings
· daily

Federal Construction & Infrastructure Contracts — April 11, 2026

The analyzed contracts total $173,694,639 in obligations, representing a fully civilian award with 0/1 defense-related, dominated by the Department of State's AQM Momentum office for overseas construction. BL Harbert International LLC secured this single firm fixed-price contract via full and open competition for the $173,694,639 NEC - Podgorica Montenegro project under NAICS 236220, signaling neutral investment implications with average strength 4/10 and materiality 3/10. The highest-conviction signal is neutral capability in commercial/institutional building construction amid a 7.5-year performance period to March 2027. No dominant sector trends emerge from this lone contract. Key risk is high pricing risk under firm fixed-price terms with $0 outlayed to date.

1 total filings
· daily

VA Healthcare & Services Contracts — April 11, 2026

The VA Healthcare & Services Contracts stream delivered a single $518,959,505 obligation to ORACLE HEALTH GOVERNMENT SERVICES, INC., representing a 100% civilian award with zero defense-related activity during the April 11, 2026 period. This firm fixed-price, non-competed delivery order for EHRM Operations under PSC DA01 underscores VA's commitment to multi-year IT systems support, with a bullish signal driven by the substantial $518,959,505 obligation and potential upside to $632,834,475 including options. The highest-conviction signal favors ORACLE HEALTH GOVERNMENT SERVICES, INC. in stable VA IT services, highlighting its role in electronic health record modernization. A key risk is the current $0 outlays with high pricing risk under firm fixed price terms, warranting close monitoring of outlay progress and option exercises through the 2027-04-10 end date.

1 total filings
· daily

New Federal Contractors — April 11, 2026

Three new federal contracts totaling $1,236,299,978 in obligations, with 1/3 defense-related, highlight civilian agency IT and construction spending via GSA, VA, and Department of State awards to Leidos, Inc. ($543.6M), Oracle Health Government Services, Inc. ($519.0M), and BL Harbert International LLC ($173.7M). Dominant theme is mature civilian IT delivery orders with significant backlog but zero or negative outlays to date. Highest-conviction bullish signal is Oracle's $519M VA EHRM operations contract (materiality 8/10, strength 7/10), signaling stable multi-year revenue in VA IT services. Key risk is high pricing risk on firm-fixed-price structures for Oracle and BL Harbert, compounded by unexercised options and $0 outlays across all contracts. Watch outlay progress and option exercises through 2027 end dates.

3 total filings
· daily

Significant Contract Modifications ($10M+) — April 11, 2026

Significant contract modifications totaling $1,236,299,978 from April 11, 2026, feature 1/3 defense-related obligations amid predominantly civilian IT and construction sectors. Dominant themes center on GSA and VA IT delivery orders, with Leidos ($543.6M) and Oracle Health Government Services ($519.0M) providing the highest materiality bullish signals for funded backlogs in mature multi-year contracts. BL Harbert International's $173.7M State Department construction award adds neutral exposure to overseas projects. Highest-conviction signal is Oracle's $519M VA EHRM operations delivery order (materiality 8/10, strength 7/10), signaling stable VA IT demand. Key risk: $0 outlays on Oracle and BL Harbert contracts plus Leidos' negative $-1.7M outlay flag execution delays and uncertain revenue ramps.

3 total filings